Endoscopic diagnosis of ulcerative colitis
https://doi.org/10.51922/2074-5044.2025.1.52
Abstract
Currently, inflammatory bowel diseases (IBD), in particular ulcerative colitis (ulcerative colitis), are an extremely urgent problem. The incidence of ulcerative colitis worldwide is increasing every year, and mainly among the working-age population, which makes inflammatory bowel disease a socially significant disease. The clinical picture of IBD is diverse, which often makes it difficult to diagnose and prescribe adequate therapy in a timely manner and inevitably negatively affects the prognosis of the disease. Endoscopic helps in the diagnosis of inflammatory bowel diseases (IBD).
About the Authors
S. A. AlekseevBelarus
O. A. Fateeva
Belarus
N. A. Lagodich
Belarus
O. F. Antiperovich
Belarus
V. S. Derkachev
Belarus
I. L. Mukovozova
Belarus
References
1. Ob utverzhdenii klinicheskogo protokola «Diagnostika i lechenie patsientov s zabolevaniyami organov pishchevareniya: Postanovlenie Ministerstva zdravookhraneniya Respubliki Belarus‘, 1 iyunya 2017 g. № 54. Available at: https://prosmp.by/normativnye-akty/protokoly-lecheniya/postanovlenie-mz-rb-%E2%84%9654-ot-01.06.2017.html. (in Russian).
2. Sekacheva M. I. Sovremennye aspekty lecheniya nespetsificheskogo yazvennogo kolita: rezul‘taty meditsiny, osnovannoi na dokazatel‘stvakh. Consilium Medicum. 2003;5(3):18–22. (in Russian).
3. Golofeevskii V. Yu., Gerasimova A. V., Sitkin S. I. Opyt primeneniya vysokikh doz mesalazina (salofal‘ka) pri lechenii tyazhelykh variantov obostreniya yazvennogo kolita. Gastroenterologiya Sankt-Peterburga. 2002;(4):20–21. (in Russian).
4. Shivananda S., Lennard-Jones J., Logan R. et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39(5): 690–697.
5. Abdulkhakov S. R., Abdulkhakov R. A. Nespetsificheskii yazvennyi kolit: sovremennye podkhody k diagnostike i lecheniyu. Vestnik Sovremennoi Klinicheskoi Mediciny [The Bulletin of Contemporary Clinical Medicine]. 2009;2(1):32–41. (in Russian).
6. Glavnov P. V., Lebedeva N. N., Kashchenko V. A., Varzin S. A. Yazvennyi kolit i bolezn’ Krona. Sovremennoe sostoyanie problemy etiologii, rannei diagnostiki i lecheniya (obzor literatury). Vestnik of Saint Petersburg University. Medicine. 2015;(4):48–72. (in Russian).
7. Magro F., Gionchetti P., Eliakim R. et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Preg nancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. Journal of Crohn’s and Colitis. 2017; 11(6):649–70. http: // doi.org/10.1093/ecco-jcc/jjx008
8. Annese V., Daperno M., Rutter M. D. et al. European evidence based consensus for endoscopy in inflammatory bowel disease. Journal of Crohn’s and Colitis. 2013;7(12):982–1018. http: // doi.org/10.1016/j.crohns.2013.09.016
9. Abdelrazeq A. S., Wilson T. R., Leitch D. L. et al. Ileitis in Ulcerative Colitis: Is It a Backwash? Diseases of the Colon & Rectum. 2005;48(111):2038–2046. https://doi.org/10.1007/s10350-005-0160-3
10. Ben-Horin S., Margalit M., Bossuyt P. et al. Prevalence and clinical impact of endoscopic pseudo- membranes in patients with inflammatory bowel disease and Clostridium difficile infection. Journal of Crohn’s and Colitis. 2010;4(2):194–8. http://doi.org/10.1016/j.crohns.2009.11.001
11. Silverberg M. S., Satsangi J., Ahmad T. et al. Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian Journal of Gastroenterology. 2005;19(suppl a):5A 36A. http://doi.org/10.1155/2005/269076
12. Gorgun J. V., Barauniova K. A., Stolyarova T. A. et al. Inflammatory bowel diseases’ epidemiology in Belarus. Gastroenterologiya Sankt-Peterburga. 2018; (1):4–11. (in Russian).
13. El Miedany Y., Youssef S., Ahmed I., El Gaafary M. The Gastrointestinal Safety and Effect on Disease Activity of Etoricoxib, a Selective Cox-2 Inhibitor in Inflammatory Bowel Diseases. The American Journal of Gastroenterology. 2006;101(2):311–317. http://doi.org/10.1111/j.1572-0241.2006.00384.x
14. Travis S. P. L., Schnell D., Krzeski P. et al. Reliability and Initial Validation of the Ulcerative Co- litis Endoscopic Index of Severity. Gastroenterology. 2013; 145(5):987–995. http://doi.org/10.1053/j.gastro.2013.07.024
15. Klassifikatsiya yazvennogo kolita po Schroeder v zavisimosti ot endoskopicheskoi aktivnosti. Available at: https://endoexpert.ru/stati/klassifikatsiya-yazvennogo-kolita-v-zavisimosti-ot-endoskopicheskoy-aktivnosti. (accessed 30.07.2024). (in Russian).
16. Rameshshanker R. Endoscopy in inflammatory bowel disease when and why. World Journal of Gastrointestinal Endoscopy. 2012;4(6):201–211. http://doi.org/10.4253/wjge.v4.i6.201
17. Zou X., Cao J., Yao Y. et al. Endoscopic Findings and Clinicopathologic Characteristics of Ischemic Colitis: A Report of 85 Cases. Digestive Diseases and Sciences. 2008;54(9):2009–2015. http://doi.org/10.1007/s10620-008-0579-1
18. Beppu K., Osada T., Nagahara A. et al. Relationship Between Endoscopic Findings and Clinical Severity in Ischemic Colitis. Internal Medicine. 2011;50(20): 2263–2267. http://doi.org/10.2169/internalmedicine.50.5349
19. Visе-Khripunova M. A., Kashirina A. N., Mukaneeva D. K. et al. Clinical-endoscopic characteristics of inflammatory bowel disease. Ulyanovsk Medico-biological Journal. 2014;(4):38–44. (in Russian).
Review
For citations:
Alekseev S.A., Fateeva O.A., Lagodich N.A., Antiperovich O.F., Derkachev V.S., Mukovozova I.L. Endoscopic diagnosis of ulcerative colitis. Military Medicine. 2025;(1):52-61. (In Russ.) https://doi.org/10.51922/2074-5044.2025.1.52
JATS XML